[1] GUO Y,TIAN X,WANG X F,et al.Adverse effects of immunoglobulin therapy[J]. Front Immunol,2018,9: 1299. [2] 金晓红,屈柯暄,陈蕊,等. 静脉丙种球蛋白致婴幼儿产生IgG类抗体及交叉配血不合6例[J]. 中国输血杂志,2021, 34(7):776-778. [3] 陈旭升,杨永涛. 静脉输注丙种球蛋白对非新生儿溶血患儿交叉配血的影响[J]. 临床输血与检验,2023,25(6): 749-752. [4] 尚红,王毓三,申子瑜. 全国临床检验操作规程[M].4版. 北京:人民卫生出版社,2015:118-143. [5] 李茂军,陈昌辉,吴青,等. 静脉注射丙种球蛋白治疗新生儿溶血症的系统评价[J]. 中国循证医学杂志,2010, 10(10):1199-1204. [6] KILBY M D,BUSSEL J B,MOISE K J Jr. The contemporary management of haemolytic disease of the fetus and newborn[J]. Vox Sang,2025,120(7):644-652. [7] 王慧欣,吴明昌,杨彩云,等. 静脉注射丙种球蛋白治疗14例新生儿Rh溶血病的临床观察[J]. 中华围产医学杂志,2002,5(1):49-51. [8] 陈男,丁婧,申家阳,等. 静注人免疫球蛋白(pH4)联合光疗治疗新生儿溶血性黄疸的临床效果[J]. 临床合理用药, 2025,18(25):128-130. [9] AL-LAWAMA M,BADRAN E,ELRIMAWI A,et al.Intravenous immunoglobulins as adjunct treatment to phototherapy in isoimmune hemolytic disease of the newborn: a retrospective case-control study[J]. J Clin Med Res,2019,11(11):760-763. [10] 王雪琴. 不同剂量丙种球蛋白联合蓝光治疗新生儿ABO溶血病的临床疗效观察[D]. 湖北医药学院,2023. [11] BALLOW M. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders[J]. J Allergy Clin Immunol, 2011,127(2):315-323;quiz324-5. [12] WALLENHORST C,PATEL A,SHEBL A,et al.Anti-A/B isoagglutinin reduction in an intravenous immunoglobulin product and risk of hemolytic Anemia: a hospital-based cohort study[J]. Transfusion,2020, 60(7):1381-1390. |